These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28644216)

  • 1. What do PAs need to know about prescription drug monitoring programs?
    Mospan GA; Lucas A
    JAAPA; 2017 Jul; 30(7):11-12. PubMed ID: 28644216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs.
    Carnes NA; Wright ER; Norwood CW
    Res Social Adm Pharm; 2017 Nov; 13(6):1167-1174. PubMed ID: 28007411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug monitoring programs and death rates from drug overdose.
    Paulozzi LJ; Kilbourne EM; Desai HA
    Pain Med; 2011 May; 12(5):747-54. PubMed ID: 21332934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it.
    Paulozzi LJ; Weisler RH; Patkar AA
    J Clin Psychiatry; 2011 May; 72(5):589-92. PubMed ID: 21536000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of Physicians' Perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP).
    Blum CJ; Nelson LS; Hoffman RS
    J Subst Abuse Treat; 2016 Nov; 70():35-43. PubMed ID: 27692186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the present state and potential of Medicaid controlled substance lock-in programs.
    Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2014 May; 20(5):439-46c. PubMed ID: 24761815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Prescription Drug Monitoring Programs to Address Drug Abuse.
    Hansen M
    NCSL Legisbrief; 2015 Mar; 23(12):1-2. PubMed ID: 26173300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A history of being prescribed controlled substances and risk of drug overdose death.
    Paulozzi LJ; Kilbourne EM; Shah NG; Nolte KB; Desai HA; Landen MG; Harvey W; Loring LD
    Pain Med; 2012 Jan; 13(1):87-95. PubMed ID: 22026451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
    Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
    N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription drug abuse: an epidemic dilemma.
    DuPont RL
    J Psychoactive Drugs; 2010 Jun; 42(2):127-32. PubMed ID: 20648908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.
    Patrick SW; Fry CE; Jones TF; Buntin MB
    Health Aff (Millwood); 2016 Jul; 35(7):1324-32. PubMed ID: 27335101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug abuse: problem, policies, and implications.
    Phillips J
    Nurs Outlook; 2013; 61(2):78-84. PubMed ID: 23245611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.
    De Marco Centeno P; Baig M; Lee SE; Lane CJ; Lagomasino IT
    J Psychiatr Pract; 2015 Nov; 21(6):412-8. PubMed ID: 26554323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
    Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
    J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1487-92. PubMed ID: 22048730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.